Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Presented for research literature review only Henninge J et al
F.DrynanL.FanJ.CurryA.FraserG.et al (2019)
The award funds research until December 31, 2021
Tirzepatide (22.5%) and Semaglutide (15%) are both FDA-approved and available today, with Tirzepatide showing superior results and better tolerability than Semaglutide
Description Tesamorelin 11mg + Ipamorelin 6mg Blend (17mg Total) Lyophilized Research Peptide Tesamorelin 11mg + Ipamorelin 6mg is a blended, lyophilized peptide vial designed for research exploring GH/IGF-1 axis signaling, pituitary secretory dynamics, and endocrine-related biomarker readouts
Summary Bottom line: Early human studies suggest GLP-1 drugs (e.g., semaglutide/Ozempic/Wegovy and tirzepatide/Mounjaro/Zepbound) can reduce alcohol cravings and sometimes heavy drinkingbut none are FDA-approved for Alcohol Use Disorder (AUD) yet
